Internal Medicine, Gastroenterology · Brooksville, FL
NPI
1417918988
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
15205 Cortez Blvd
Brooksville, FL, 34613
Phone (352) 597-7744
Groups this clinician bills Medicare through
Medicare paid, 2024
$469K
3,425 services
Medicare patients, 2024
1,096
Average age 76
Drug cost, 2024
$2.2M
5,909 prescriptions
Company payments, 2025
$1,617
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Azzam Muftah was code 99214 (office e&m - established), 740 times for 451 patients. In total Azzam Muftah billed 3,425 services in 47 codes, and Medicare paid $469K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-04-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 740 | 451 | $94.57 | $70K |
| 99213 Office E&M - Established | Office | 588 | 492 | $66.99 | $39K |
| 99232 Hospital E&M - Subsequent | Facility | 488 | 173 | $61.35 | $30K |
| 99204 Office E&M - New | Office | 295 | 295 | $118.36 | $35K |
| 43239 Upper GI Endoscopy | Office | 193 | 180 | $92.98 | $18K |
| 99223 Hospital E&M - Initial | Facility | 157 | 138 | $134.27 | $21K |
| 43249 Upper GI Endoscopy | Office | 149 | 137 | $790.61 | $118K |
| 99233 Hospital E&M - Subsequent | Facility | 107 | 99 | $92.29 | $9,875 |
| 99215 Office E&M - Established | Office | 91 | 78 | $133.04 | $12K |
| 46221 Digestive/Gastrointestinal | Office | 84 | 40 | $206.80 | $17K |
| 91110 Standard X-ray | Office | 69 | 34 | $271.36 | $19K |
| 43251 Upper GI Endoscopy | Office | 57 | 55 | $198.37 | $11K |
| 43239 Upper GI Endoscopy | Facility | 55 | 54 | $98.71 | $5,429 |
| 45380 Lower GI Endoscopy - Other | Office | 55 | 54 | $156.43 | $8,604 |
| 46600 Digestive/Gastrointestinal | Office | 47 | 43 | $84.29 | $3,962 |
By year: 2022 $379K for 3,393 services; 2023 $379K for 3,061 services; 2024 $469K for 3,425 services.
Medicare prescription drug claims, 2024
In 2024, the drug Azzam Muftah prescribed most often to Medicare patients was Omeprazole, with 1,411 prescriptions and refills. In total Azzam Muftah wrote 5,909 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 1,411 | 3,293 | 586 | $20K |
| Pantoprazole Sodium Generic | 683 | 1,584 | 265 | $13K |
| Gavilyte-C Peg3350/Sod Sulf,bicarb,cl/Kcl | 605 | 605 | 582 | $11K |
| Linzess Linaclotide | 287 | 553 | 83 | $287K |
| Metronidazole Generic | 259 | 259 | 241 | $2,267 |
| Famotidine Generic | 250 | 583 | 106 | $3,515 |
| Mesalamine Generic | 143 | 247 | 33 | $109K |
| Cholestyramine Cholestyramine (With Sugar) | 129 | 204 | 71 | $13K |
| Lactulose Generic | 125 | 179 | 64 | $4,985 |
| Dicyclomine Hcl Generic | 124 | 247 | 63 | $3,911 |
| Sucralfate Generic | 115 | 149 | 73 | $4,238 |
| Azathioprine Generic | 114 | 254 | 28 | $18K |
| Budesonide Dr Budesonide | 106 | 123 | 49 | $27K |
| Ondansetron Hcl Generic | 88 | 104 | 64 | $7,897 |
| Esomeprazole Magnesium Generic | 87 | 192 | 35 | $2,949 |
Brand drugs: - claims; generic drugs: 5,128 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Azzam Muftah $1,617 ($1,617 in general payments such as food, travel and fees) from 13 companies. The largest payer was Abbvie Inc. with $463.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 26 | $463 |
| Pfizer Inc. PFE | 16 | $240 |
| Janssen Biotech, Inc. JNJ | 7 | $158 |
| Ardelyx, Inc. ARDX | 10 | $142 |
| Phathom Pharmaceuticals, Inc. PHAT | 5 | $130 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 5 | $97.72 |
| Regeneron Healthcare Solutions, Inc. REGN | 3 | $71.3 |
| Madrigal Pharmaceuticals MDGL | 2 | $68.8 |
| Gilead Sciences, Inc. GILD | 3 | $65.96 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 3 | $62.26 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.